Latest period
$57.32B
YoY change
-9.1%
5Y CAGR
+10.6%
Peak year (2023)
$64.61B
Latest annual
$54.60B
Total Debt history chart for Amgen (AMGN) from 1985 to 2025
Latest: $54.60B
Total Debt growth chart for Amgen (AMGN) from 1985 to 2025
Latest: -9.1%
Total Debt history table for Amgen (AMGN) from 1985 to 2025
| 2025 | $54.60B | -9.1% | −$5.50B | ||
| 2024 | $60.10B | -7.0% | −$4.51B | ||
| 2023 | $64.61B | +65.9% | +$25.67B | ||
| 2022 | $38.95B | +16.9% | +$5.64B | ||
| 2021 | $33.31B | +1.0% | +$323.00M | ||
| 2020 | $32.99B | +10.3% | +$3.08B | ||
| 2019 | $29.90B | -11.9% | −$4.03B | ||
| 2018 | $33.93B | -4.0% | −$1.41B | ||
| 2017 | $35.34B | +2.2% | +$746.00M | ||
| 2016 | $34.60B | +10.1% | +$3.17B | ||
| 2015 | $31.43B | +2.3% | +$714.00M | ||
| 2014 | $30.71B | -4.4% | −$1.41B | ||
| 2013 | $32.13B | +21.1% | +$5.60B | ||
| 2012 | $26.53B | +23.8% | +$5.10B | ||
| 2011 | $21.43B | +60.4% | +$8.07B | ||
| 2010 | $13.36B | +26.0% | +$2.76B | ||
| 2009 | $10.60B | +4.2% | +$425.00M | ||
| 2008 | $10.18B | -9.0% | −$1.00B | ||
| 2007 | $11.18B | +24.0% | +$2.17B | ||
| 2006 | $9.01B | +127.7% | +$5.05B | ||
| 2005 | $3.96B | -22.6% | −$1.15B | ||
| 2004 | $5.11B | +65.9% | +$2.03B | ||
| 2003 | $3.08B | -2.9% | −$91.00M | ||
| 2002 | $3.17B | +882.0% | +$2.85B | ||
| 2001 | $322.90M | +0.1% | +$200.00K | ||
| 2000 | $322.70M | +0.1% | +$200.00K | ||
| 1999 | $322.50M | -1.9% | −$6.20M | ||
| 1998 | $328.70M | +26.9% | +$69.70M | ||
| 1997 | $259.00M | +46.2% | +$81.80M | ||
| 1996 | $177.20M | -28.2% | −$69.70M | ||
| 1995 | $246.90M | -12.8% | −$36.20M | ||
| 1994 | $283.10M | -2.7% | −$7.90M | ||
| 1993 | $291.00M | +120.6% | +$159.10M | ||
| 1992 | $131.90M | +217.8% | +$90.40M | ||
| 1991 | $41.50M | +186.2% | +$27.00M | ||
| 1990 | $14.50M | — | — | ||
| 1988 | $32.20M | +74.1% | +$13.70M | ||
| 1987 | $18.50M | +143.4% | +$10.90M | ||
| 1986 | $7.60M | -14.6% | −$1.30M | ||
| 1985 | $8.90M | — | — |
- 2025$54.60B-9.1%
- 2024$60.10B-7.0%
- 2023$64.61B+65.9%
- 2022$38.95B+16.9%
- 2021$33.31B+1.0%
- 2020$32.99B+10.3%
- 2019$29.90B-11.9%
- 2018$33.93B-4.0%
- 2017$35.34B+2.2%
- 2016$34.60B+10.1%
- 2015$31.43B+2.3%
- 2014$30.71B-4.4%
- 2013$32.13B+21.1%
- 2012$26.53B+23.8%
- 2011$21.43B+60.4%
- 2010$13.36B+26.0%
- 2009$10.60B+4.2%
- 2008$10.18B-9.0%
- 2007$11.18B+24.0%
- 2006$9.01B+127.7%
- 2005$3.96B-22.6%
- 2004$5.11B+65.9%
- 2003$3.08B-2.9%
- 2002$3.17B+882.0%
- 2001$322.90M+0.1%
- 2000$322.70M+0.1%
- 1999$322.50M-1.9%
- 1998$328.70M+26.9%
- 1997$259.00M+46.2%
- 1996$177.20M-28.2%
- 1995$246.90M-12.8%
- 1994$283.10M-2.7%
- 1993$291.00M+120.6%
- 1992$131.90M+217.8%
- 1991$41.50M+186.2%
- 1990$14.50M—
- 1988$32.20M+74.1%
- 1987$18.50M+143.4%
- 1986$7.60M-14.6%
- 1985$8.90M—
Total Debt values are taken from Amgen's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at Amgen (AMGN)
According to Amgen's latest reported financial statements, the company's latest reported total debt is $57.32B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Amgen (AMGN) total debt totalled $54.60B – declined 9.1% year-over-year.
Amgen total debt has grown on net over the period, with a +10.6% compound annual growth rate over 2020–2025 (5 years).
Across the available history, total debt reached its high of $64.61B in 2023 and its low of $7.60M in 1986.
Amgen Total Debt by Year
Amgen Total Debt 2025: $54.60B
In 2025, Amgen reported total debt of $54.60B, declined 9.1% below 2024.
Amgen Total Debt 2024: $60.10B
Amgen total debt in 2024 was $60.10B, declined 7.0% below 2023.
Amgen Total Debt 2023: $64.61B
2023's total debt for Amgen came in at $64.61B, surged 65.9% from 2022. This figure represents the highest annual value in the available history.
Amgen Total Debt 2022: $38.95B
Amgen posted total debt of $38.95B in 2022, grew 16.9% from 2021.
Amgen Total Debt 2021: $33.31B
Amgen total debt in 2021 was $33.31B.
See more financial history for Amgen (AMGN).
Sector peers by Total Debt
Healthcare peers of Amgen (AMGN), ranked by their latest total debt
| $78.39B | |
| $69.07B | |
| $50.53B | |
| $47.93B | |
| $42.50B | |
| $40.85B | |
| $29.70B | |
| $20.59B |
- $78.39B
- $69.07B
- $50.53B
- $47.93B
- $42.50B
- $29.70B
- $20.59B
Frequently asked questions
Amgen (AMGN) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation